{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T14:07:34Z","timestamp":1708006054214},"reference-count":37,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.humimm.2004.05.006","type":"journal-article","created":{"date-parts":[[2004,7,24]],"date-time":"2004-07-24T14:25:55Z","timestamp":1090679155000},"page":"839-846","source":"Crossref","is-referenced-by-count":7,"title":["Association of a novel single nucleotide polymorphism in the human perforin gene with the outcome of HTLV-I infection in patients from Northeast Iran (Mash-had)"],"prefix":"10.1016","volume":"65","author":[{"given":"Houshang","family":"Rafatpanah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Pravica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Farid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Reza","family":"Abbaszadegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Tabatabaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Goharjoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Mehdi","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian V.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2004.05.006_bib1","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukaemia","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humimm.2004.05.006_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"2","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2004.05.006_bib3","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0140-6736(98)09460-4","article-title":"Human T-lymphotropic virus type I infection","author":"Manns","year":"1999","journal-title":"Lancet 353"},{"key":"10.1016\/j.humimm.2004.05.006_bib4","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/aid.1996.12.1185","article-title":"Prevalence of HTLV type I infection in Iran","volume":"12","author":"Safai","year":"1996","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.humimm.2004.05.006_bib5","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/JCM.41.6.2593-2595.2003","article-title":"Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran","volume":"41","author":"Abbaszadegan","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.humimm.2004.05.006_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0022-510X(92)90215-7","article-title":"Antibody titers to HTLV-I-p40 Tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"107","author":"Kira","year":"1992","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.humimm.2004.05.006_bib7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.410290214","article-title":"Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy","volume":"29","author":"Kira","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.humimm.2004.05.006_bib8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.177.6.1567","article-title":"High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease","volume":"177","author":"Elovaara","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2004.05.006_bib9","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0042-6822(92)90517-S","article-title":"Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis","volume":"188","author":"Parker","year":"1992","journal-title":"Virologyd"},{"key":"10.1016\/j.humimm.2004.05.006_bib10","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1128\/JVI.66.5.2928-2933.1992","article-title":"Target epitope in the Tax protein of human T-cell leukaemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells","volume":"66","author":"Kannagi","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2004.05.006_bib11","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.4049\/jimmunol.151.7.3874","article-title":"Characterization of MHC class I restricted cytotoxic T cell responses to Tax in HTLV-1 infected patients with neurologic disease","volume":"151","author":"Koenig","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib12","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1073\/pnas.96.7.3848","article-title":"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy","volume":"96","author":"Jeffery","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humimm.2004.05.006_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/317932","article-title":"Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax 11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis","volume":"183","author":"Nagai","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.humimm.2004.05.006_bib14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.162.3.1765","article-title":"Direct analysis of viral-specific CD8+ T cells with soluble HLA-A2\/Tax 11\u201319 tetramer complexes in patients with human T cell lymphotropic virus-associated myelopathy","volume":"162","author":"Bieganowska","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0952-7915(00)00107-2","article-title":"The immune response to HTLV-I","volume":"12","author":"Bangham","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/smvy.1996.0006","article-title":"The cytotoxic T-lymphocyte's response to HTLV-I","volume":"7","author":"Bangham","year":"1996","journal-title":"Semin Virol"},{"key":"10.1016\/j.humimm.2004.05.006_bib17","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.159.4.2018","article-title":"Human T cell leukaemia virus type I (HTLV-I)- specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase","volume":"159","author":"Biddison","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.iy.03.040185.000335","article-title":"Mechanism of lymphocyte-mediated cytotoxicity","volume":"3","author":"Henkart","year":"1985","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.immunol.14.1.207","article-title":"Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo","volume":"14","author":"Kagi","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0952-7915(98)80227-6","article-title":"How do cytotoxic lymphocytes kill their targets?","volume":"10","author":"Shresta","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.iy.09.040191.001021","article-title":"A central role of perforin in cytolysis?","volume":"9","author":"Podack","year":"1991","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0167-5699(95)80121-9","article-title":"Perforin","volume":"16","author":"Liu","year":"1995","journal-title":"Immunol Today"},{"key":"10.1016\/j.humimm.2004.05.006_bib23","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.7518614","article-title":"Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity","volume":"265","author":"Kagi","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.humimm.2004.05.006_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/369031a0","article-title":"Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice","volume":"369","author":"Kagi","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2004.05.006_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1074-7613(00)00065-0","article-title":"Fratricide among CD8(+) T lymphocytes naturally infected with human T cell lymphotropic virus type I","volume":"13","author":"Hanon","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2004.05.006_bib26","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","article-title":"Abundant Tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes","volume":"95","author":"Hanon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2004.05.006_bib27","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.humimm.2004.05.006_bib28","first-page":"382","article-title":"Report of the scientific group on HTLV-I and associated diseases, Kagoshima, Japan, December 1988virus disease","volume":"49","year":"1989","journal-title":"WHO Wkly Epidemiol Rec"},{"key":"10.1016\/j.humimm.2004.05.006_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.187.5.763","article-title":"Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology","volume":"187","author":"Ehl","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.humimm.2004.05.006_bib30","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/JVI.75.5.2458-2461.2001","article-title":"Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection","volume":"75","author":"Vogel","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2004.05.006_bib31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1128\/JVI.76.2.829-840.2002","article-title":"Critical role for perforin-, Fas\/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection","volume":"76","author":"Zhou","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2004.05.006_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2002-03-0791","article-title":"Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic","volume":"101","author":"Zhang","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2004.05.006_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0167-5699(99)01444-9","article-title":"Faces and phases of human CD8 T-cell development","volume":"20","author":"Hamann","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.humimm.2004.05.006_bib34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1098\/rstb.1999.0422","article-title":"Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I","volume":"354","author":"Bangham","year":"1999","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.humimm.2004.05.006_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0165-5728(98)00147-7","article-title":"Predominant expression of Fas ligand mRNA in CD8+ T lymphocytes in patients with HTLV-1 associated myelopathy","volume":"90","author":"Kawahigashi","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0165-5728(99)00095-8","article-title":"Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy\/tropical spastic paraparesis patients","volume":"98","author":"Saito","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.humimm.2004.05.006_bib37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s00401-001-0478-4","article-title":"Involvement of Fas\/Fas ligand system in the spinal cords of HTLV-I-associated myelopathy","volume":"103","author":"Umehara","year":"2002","journal-title":"Acta Neuropathol (Berl)"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885904001223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885904001223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T02:45:11Z","timestamp":1682736311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885904001223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0198885904001223"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2004.05.006","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}